市場調査レポート

商品コード

1463394

3Dプリント医薬品の世界市場規模、シェア、成長分析、技術タイプ別、用途別 - 産業予測、2024～2031年

Global 3D Printed Drugs Market Size, Share, Growth Analysis, By Technology Type(Inkjet Printing, Fused Deposition Modeling), By Application(Orthopaedic, Neurology) - Industry Forecast 2024-2031

出版日: 2024年04月06日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 830,510円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 971,540円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,112,570円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.70円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の3Dプリント医薬品の市場規模は、2022年に8,491万米ドルとなり、予測期間中（2024～2031年）のCAGRは16%で、2023年の9,850万米ドルから、2031年までには3億2,291万米ドルに成長する見通しです。

製薬業界では、3Dプリント医薬品市場が世界規模で急速に拡大しています。3Dプリンティング技術を使ってオーダーメイドできる医薬製剤の数が増えており、薬の効能を高め、副作用を軽減し、個別の投与量を提供することができます。3Dプリンティングの方法は、3次元の物体を作成するために材料の連続した層を堆積させることです。医薬品製造の文脈では、これは基板上に正確な投薬量を印刷することを意味します。市場は北米、欧州、アジア太平洋が支配しています。市場の拡大は、カスタマイズされた医薬品に対するニーズの高まり、技術の向上、正確な投与量を提供し悪影響を最小限に抑える3Dプリンティングの能力に起因しています。3Dプリント医薬品市場は、患者の転帰を向上させ医療費を削減する可能性のある医薬品を製造するための斬新で独創的なアプローチを提供することを目的としています。薬の製造に3Dプリンティング技術を使用することで、無駄が少なく、設計の自由度が高い薬がオンデマンドで製造される可能性があります。医療費削減の必要性、技術改善、正確な投与と副作用防止を実現する3Dプリンティングの可能性、個別化された医薬品へのニーズの高まりが、3Dプリント医薬品市場の成長を後押しする主要な要因です。3Dプリント技術のコストが高く、規制機関から3Dプリント医薬品の承認を得るのが難しいことが、3Dプリント医薬品産業の成長を阻害する主要な問題です。3Dプリント医薬品の市場には、これらの製品の有効性と安全性を保証するためにさらなる研究開発が必要であること、3Dプリント手順を標準化する必要があること、知的財産権の問題が発生する可能性があることなど、いくつかの障害があります。斬新で独創的な薬剤組成物の創出、新しい地域への市場の成長機会、3Dプリンティングが個別化医療とドラッグデリバリーに革命をもたらす可能性などは、3Dプリント医薬品市場における機会の1つです。製薬企業にとって、医薬品製造における3Dプリンティング技術の利用は、新たな収益源を開拓する可能性があります。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要な投資の分析
主要な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

世界の3Dプリント医薬品市場：技術タイプ別

市場概要
インクジェット印刷
熱溶解積層法
ステレオリソグラフィー
ジップドーズテクノロジー

世界の3Dプリント医薬品市場：用途別

市場概要
整形外科
神経学
歯科
その他

世界の3Dプリント医薬品市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Aprecia Pharmaceuticals-（US）
FabRx-（UK）
GlaxoSmithKline-（UK）
Pfizer-（US）
Merck-（US）
Sanofi-（France）
3D Systems-（US）
BASF-（Germany）
Teva Pharmaceuticals-（Israel）
Novartis-（Switzerland）
Roche-（Switzerland）
Catalent-（US）
Johnson & Johnson-（US）
Vertex Pharmaceuticals-（US）
Boehringer Ingelheim-（Germany）
Siemens Healthineers-（Germany）
Sandoz International-（Germany）
BioBots-（US）
Apium Additive Technologies-（Germany）
Boston Micro Fabrication-（US）

Product Code: SQMIG35I2140

Global 3D Printed Drugs Market size was valued at USD 84.91 Million in 2022 and is poised to grow from USD 98.5 Million in 2023 to USD 322.91 Million by 2031, at a CAGR of 16% during the forecast period (2024-2031).

Within the pharmaceutical industry, the 3D printed drug market is expanding quickly on a global scale. A growing number of pharmaceutical formulations can be made to order using 3D printing technology, which can increase medication efficacy, lessen side effects, and offer individualized dosage. The method of 3D printing is depositing consecutive layers of material to create a three-dimensional object. In the context of drug production, this entails printing exact medication dosages onto a substrate. The market is dominated by North America, Europe, and Asia Pacific. The market's expansion can be ascribed to the rising need for customized medications, technological improvements, and 3D printing's capacity to deliver accurate dosage and minimize negative effects. The market for 3D printed medications aims to offer a fresh and inventive approach to producing medications that might enhance patient outcomes and lower medical expenses. Drugs may be produced on demand, with less waste and more design freedom thanks to the use of 3D printing technology in medication manufacturing. The need to lower healthcare costs, technological improvements, the potential of 3D printing to deliver exact dosing and prevent side effects, and the growing need for individualized medications are the main factors propelling the growth of the 3D printed drugs market. The high cost of 3D printing technology and the difficulties in getting 3D printed drug approval from regulatory bodies are the main issues impeding the growth of the 3D printed drug industry. The market for 3D printed medications has several obstacles, such as the requirement for more research and development to guarantee the efficacy and safety of these products, the requirement to standardize 3D printing procedures, and the possibility of intellectual property issues. The creation of novel and inventive medication compositions, the market's growth into new geographic areas, and the possibility for 3D printing to revolutionize personalized medicine and drug delivery are among the opportunities in the 3D printed pharmaceuticals market. For pharmaceutical businesses, the use of 3D printing technology in drug manufacture could open up new revenue sources.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 3D Printed Drugs Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 3D Printed Drugs Market Segmental Analysis

The global 3D printed drugs market is segmented on the basis of product, application, and region. By technology, the market is segmented into inkjet printing, fused deposition modeling, stereolithography, zipdose technology. By application, the market is segmented into orthopedic, neurology, dental, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 3D Printed Drugs Market

The global market for 3D printed drugs is mostly driven by the rising need for customized medications. Medications that are customized for each patient based on their genetics, lifestyle, and surroundings are known as personalized medicines. Compared to conventional medications, these medications provide a number of benefits, including as greater efficacy, fewer side effects, and higher patient compliance. 3D printing technology is perfect for producing tailored pharmaceuticals since it allows the fabrication of unique drug compositions with accurate dosing and drug release characteristics. Pharmaceutical businesses can now produce medications with distinctive formulas and geometries that are not possible with conventional manufacturing techniques thanks to 3D printing. The necessity for focused drug administration and the growing incidence of chronic diseases are driving up demand for personalized medicines. Long-term care is necessary for chronic conditions like cancer, diabetes, and cardiovascular disease, and individualized medication can enhance patient outcomes and quality of life. Targeted medication administration can also lower the dosage needed, which will lessen adverse effects and increase patient compliance. The market for 3D printed medications is anticipated to expand rapidly in the upcoming years. Global demand for 3D printed drugs is predicted to rise quickly due to the growing need for customized medications and technological developments in this field.

Restraints in the Global 3D Printed Drugs Market

The substantial upfront costs associated with 3D printing hardware, software, and supplies make it challenging for small and medium-sized pharmaceutical enterprises to implement the technology. Because of the high cost of materials and the length of time needed for production, 3D printed medications may have a greater cost per unit than conventional pharmaceuticals. This may result in patients finding 3D printed medications less affordable, which would lower demand for the goods. The regulatory landscape surrounding 3D printed medications is continuously evolving, and obtaining regulatory approval can be a costly and time-consuming procedure. This may further drive up the price of 3D printed medications and restrict patient access to them.

Market Trends of the Global 3D Printed Drugs Market

Pharmaceutical businesses working together with 3D printing companies: In the global market for 3D printed drugs, partnerships between pharmaceutical corporations and 3D printing companies are become more frequent. This partnership is spurring industry innovation and accelerating the release of novel medications and drug delivery technologies. To create innovative medications and drug delivery systems, pharmaceutical companies are collaborating with 3D printing businesses. The manufacture of intricate medication formulations and customized medications with exact dosage and customized formulas is made possible by 3D printing technology. Innovation in the global market for 3D printed drugs is being driven by partnerships between pharmaceutical companies and 3D printing enterprises. This partnership is accelerating the release of new medications and drug delivery technologies, and it is anticipated to sustain industry expansion in the years to come.

Positive government initiatives: The global market for 3D printed drugs is expanding thanks in large part to positive government initiatives. Globally, numerous governments are launching programs to encourage the advancement and application of 3D printing technology in the medical field. These programs are promoting market expansion and assisting in the development of a regulatory framework that is favorable to the sector. Positive government actions are a major factor in the global market for 3D printed drugs' expansion. These programs include fostering innovation, advancing the development of novel medications and drug delivery technologies, and assisting in the establishment of a regulatory environment that is favorable to the sector.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global 3D Printed Drugs Market by Technology Type

Market Overview
Inkjet Printing
Fused Deposition Modeling
Stereolithography
and Zip Dose Technology

Global 3D Printed Drugs Market by Application

Market Overview
Orthopaedic
Neurology
Dental
and Others

Global 3D Printed Drugs Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Aprecia Pharmaceuticals - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FabRx - (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline - (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi - (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3D Systems - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF - (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals - (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis - (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche - (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Catalent - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim - (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers - (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz International - (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioBots - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apium Additive Technologies - (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Micro Fabrication - (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments